Author Archives: Stam Sarris

Dr. Dionysis Papadatos-Pastos and Dr. Liz O’Riordan share their insights on the claims and dangers of ‘natural cancer cures’ as portrayed in the Netflix series Apple Cider Vinegar

14 February 2025 Is Hirsch therapy seen in Netflix’s Apple Cider Vinegar real? Milla in the series wants a ‘natural cancer cure’ that involves juicing and enemas – here, experts to explain why sadly this approach doesn’t work. Viewers of Netflix’s Apple Cider Vinegar, based loosely on the true story of Australian wellness blogger Belle…

New Hope for Oligometastatic Non-Small Cell Lung Cancer: Breakthrough Treatments in 2025 Bringing Patients Closer to Long-Term Survival

At the 1st Cyprus Oncology Conference in Nicosia, Dr. Papadatos-Pastos delivered a compelling presentation on the role of systemic therapies in optimizing treatment outcomes for oligometastatic non-small cell lung cancer (NSCLC). He highlighted the importance of chemotherapy, along with the latest advancements in targeted therapies and immunotherapy, emphasizing their role in enhancing long-term disease control….

Better recovery for lung cancer 2025

New Year New You ’ distributed with The Guardian 4th January 2025

Better recovery for lungcancer 2025 New Year New You ’ distributed with The Guardian 4th January 2025 The article in text format: Better recovery for lung cancer 2025 Recent advances in lung cancer treatment are bringing new hope to patients, with exciting developments in immunotherapy, targeted therapies, and antibody-drug conjugates (ADCs). Immunotherapy harnesses the body’s…

Dr Papadatos-Pastos in The London Clinic Lung Cancer Awareness Month (November 2024)

A common misconception of Lung Cancer is that it’s just a smoker’s disease. Whilst smoking is a leading cause, non-smokers can also develop lung cancer due to factors like air pollution, genetic predisposition, and second-hand smoke. This Lung Cancer Awareness Month we encourage you to familiarise yourself with the main signs and symptoms of this…

New Hope for B3 Thymoma and Thymic Carcinoma: Promising Results from Multi Targeted Therapy and Immunotherapy Combination Therapy

The PECATI trial, presented at ESMO 2024, brings promising news for patients with advanced B3 thymoma and thymic carcinoma, rare types of cancer originating in the thymus gland. This study evaluated the combination of two drugs, lenvatinib and pembrolizumab, in patients who had already undergone other treatments and did not have autoimmune disorders. In the…

Dr. Papadatos-Pastos Leads Key Session on Emerging Immunotherapy Advances in Lung Cancer Treatment

Dr Papadatos-Pastos at the 5th International Meeting on Lung Cancer

The 5th International Meeting on Lung Cancer was a highly successful event, bringing together leading experts and clinicians to discuss the latest advancements in lung cancer treatment. Dr. Papadatos-Pastos, serving as a member of both the organizing and scientific committees, played a crucial role in shaping the program, which featured distinguished speakers from the US,…

Dr Papadatos-Pastos in the Evening Standard (10 September 2024)

Dr Papadatos-Pastos in the Evening Standard (10 September 2024)

Hopeful horizons for lung cancer patients As seen in the Evening Standard newspaper on September 10, 2024 The article in text format: Hopeful horizons for lung cancer patients Lung cancer treatment has made great strides in recent years, offering patients more effective options and better outcomes. Traditional treatments like surgery, chemotherapy and radiation are still…